Carnivore protoparvovirus 1

Petco Love Vaccinated & Loved Initiative Saves Vulnerable Pet Lives

Retrieved on: 
Wednesday, October 12, 2022
MSD, Adoption, SAN, LinkedIn, Petco, Schering-Plough, Risk, Diagnosis, Vaccine, Animal, Parvoviridae, Organization, Parent, Farmer, Merck & Co., Twitter, Instagram, Carnivore, Dog, PETS, Research, Investment, Multimedia, Partnership, Technology, Publishing, Rabies, Health, Intention, Distemper, HCP, Vaccination, Carnivore protoparvovirus 1, Love, Lead, Cat, Pharmaceutical industry, Merck, Access, Facebook

SAN ANTONIO, Oct. 12, 2022 /PRNewswire/ -- Petco Love, a national nonprofit spearheading positive change for pets, celebrates reaching its one-millionth free pet vaccine distribution for family pets. Today, due to the overwhelming need, Petco Love re-commits another million free vaccines through its Vaccinated and Loved initiative to help end life-threatening pet diseases.

Key Points: 
  • Today, due to the overwhelming need, Petco Love re-commits another million free vaccines through its Vaccinated and Loved initiative to help end life-threatening pet diseases.
  • The Vaccinated and Loved campaign, launched in August 2021, encourages Petco Love animal welfare partners to host free vaccine clinics, particularly targeting high-impact areas where fatal pet diseases (parvovirus and distemper in dogs, and panleukopenia in cats) are prevalent.
  • Petco Love surveyed pet parents1 attending the free clinics to assess whether the initiative met its goal to reach pets most in need.
  • Proactively vaccinating vulnerable pets saves lives," said Susanne Kogut, Petco Love president.

Statement from the Chief Public Health Officer of Canada on July 13, 2021

Retrieved on: 
Tuesday, July 13, 2021
Medical specialties, Medicine, Clinical medicine, Immunology, Vaccination, COVID-19, Vaccine, Immunity, Antibody, Carnivore protoparvovirus 1, Immunity passport

The presence of these antibodies indicates that the person has been exposed to the virus, or developed antibodies in response to vaccination.

Key Points: 
  • The presence of these antibodies indicates that the person has been exposed to the virus, or developed antibodies in response to vaccination.
  • The Public Health Agency of Canada, through the COVID-19 Immunity Task Force, has supported serosurveillance in several communities and settings.
  • During the study period, about 2.6% of people across Canada developed antibodies from a past infection and another 1% had antibodies from vaccination.
  • As public health restrictions are eased, some increase in cases, particularly among unvaccinated populations, is not unexpected.